# Pilocarpine

## Salagen 5mg

##### 

| Title              | Content                                                                                                                                                                                                        |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OSALA                                                                                                                                                                                                          |
| Indications        | Treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head & neck. Treatment of symptoms of dry mouth in patients with Sjogren's syndrome.              |
| Dosing             | Head & neck cancer - Radiation-induced xerostomia: Initially 5 mg TID. Usual dosage range: 15-30 mg daily (do not exceed 10 mg/dose). Sjogren's syndrome - Xerostomia: 5 mg QID.                               |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                  |
| Contraindications  | Uncontrolled asthma， acute iritis & angle closure glaucoma.                                                                                                                                                   |
| Adverse Effects    | Sweating， nausea， diarrhea， chills， flushing， urinary frequency， dizziness， asthenia， headache， dyspepsia， lacrimation， edema， abdominal pain， amblyopia， vomiting， pharyngitis， hypertension. |
| Pregnancy          | No (limited) human data – animal data suggest moderate risk                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                  |

